Edition:
India

Zymeworks Says FDA Granted Fast Track Designation To Lead Asset Zw25


Thursday, 30 May 2019 

May 29 (Reuters) - Zymeworks Inc ::ZYMEWORKS' LEAD ASSET, ZW25, GRANTED FAST TRACK DESIGNATION FROM THE FDA.ZYMEWORKS - ZW25 GRANTED FAST TRACK FOR TREATMENT OF THOSE WITH HER2-OVEREXPRESSING GASTROESOPHAGEAL ADENOCARCINOMA WITH STANDARD OF CARE CHEMOTHERAPY. 

Company Quote

34.89
0.0 +0.00%
8:00pm IST